Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

NCT05120284 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Dichloroacetate (DCA)
GENETIC: Genotype

Sponsor

University of Florida